Market Research Logo

Rheumatoid Arthritis Global Clinical Trials Review, H2, 2018

Rheumatoid Arthritis Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, “Rheumatoid Arthritis Global Clinical Trials Review, H2, 2018 provides an overview of Rheumatoid Arthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Rheumatoid Arthritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Rheumatoid Arthritis to Immunology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Rheumatoid Arthritis to Immunology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Rheumatoid Arthritis Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Rheumatoid Arthritis
Jul 20, 2018: Koutif Therapeutics Confirms Clinical Candidate Drug
Jun 28, 2018: Mallinckrodt Rheumatoid Arthritis Phase 4 Clinical Study for H.P. Acthar Gel (Repository Corticotropin Injection) Achieves its Enrollment Target
Jun 27, 2018: Amgen Announces Top-Line Results From Phase 3 Study Of ABP 710, Biosimilar Candidate To Infliximab
Jun 18, 2018: Mallinckrodt Reports Interim Findings Of H.P. Acthar Gel (Repository Corticotropin Injection) Studies
Jun 16, 2018: Mallinckrodt Presents Preliminary Interim Findings of Rheumatoid Arthritis Phase 4 Clinical Study for H.P. Acthar Gel (Repository Corticotropin Injection)
Jun 13, 2018: Samsung Bioepis and Biogen Announce Pooled Analysis Results of Anti-TNF Biosimilars BENEPALI (etanercept), FLIXABI (infliximab), and IMRALDI (adalimumab) at EULAR 2018
Jun 12, 2018: Celltrion Healthcare Showcases Promising Preliminary Results for New Subcutaneous Formulation of CT-P13 (biosimilar infliximab) in Patients with Rheumatoid Arthritis
Jun 12, 2018: AbbVie Presents Additional Outcomes Data from Three Upadacitinib Phase 3 Studies in Rheumatoid Arthritis at the Annual European Congress of Rheumatology (EULAR 2018)
Jun 11, 2018: Lilly to Unveil New Data on OLUMIANT at the EULAR 2018, Furthering Commitment to Scientific Discovery in Immunology
Jun 11, 2018: Lilly to Unveil New Data on Taltz at the EULAR 2018, Furthering Commitment to Scientific Discovery in Immunology
Jun 05, 2018: Upadacitinib Monotherapy Meets All Primary and Ranked Secondary Endpoints Versus Methotrexate in a Phase 3 Study in Rheumatoid Arthritis
May 29, 2018: MetrioPharm Announces Data Presentation on the Mechanism of Action of MP1032 at the 19th SFRRI Meeting in Lisbon
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
List of Tables
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Region, 2018*
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, North America, Top Countries, 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018*
Proportion of Rheumatoid Arthritis to Immunology Clinical Trials, G7 Countries (%), 2018*
Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
Proportion of Rheumatoid Arthritis to Immunology Clinical Trials, E7 Countries (%), 2018*
Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Phase, 2018*
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Phase 2018*
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Trial Status, 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, by End Point Status, 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
Rheumatoid Arthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
List of Figures
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Region (%), 2018*
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, North America, Top Countries (%), 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018*
Proportion of Rheumatoid Arthritis to Immunology Clinical Trials, G7 Countries (%), 2018*
Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
Proportion of Rheumatoid Arthritis to Immunology Clinical Trials, E7 Countries (%), 2018*
Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Phase (%), 2018*
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2018*
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Trial Status, 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, by End Point Status, 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
Rheumatoid Arthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
GlobalData Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook